Stay updated with the latest new-york-state-department-of-health news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on new-york-state-department-of-health topics.
In a recent transaction, John Aballi, President and CEO of Exagen Inc . (NASDAQ:XGN), purchased 24,305 shares of the company's common stock. The shares were acquired at a weighted average price of $2.81 per share, amounting to a total purchase value of $68,297. Following this transaction, Aballi's direct ownership in Exagen stands at 689,799 shares. This purchase reflects Aballi's continued investment in the company, as he maintains both director and officer roles within Exagen. "In other rec ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.